Barry Canton, 10% Owner at Ginkgo Bioworks Holdings, Inc. (DNA), sold 150,600 shares at $1.75 ($270K) on 2023-09-28, disclosed to the SEC on 2023-09-29.
Scheduled sale ($270k) by 10% Owner under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.83 | 37,650 | $69K | 25.6% |
| 2 | $1.83 | 37,650 | $69K | 25.6% |
| 3 | $1.75 | 37,650 | $66K | 24.4% |
| 4 | $1.75 | 37,650 | $66K | 24.4% |
| Total | $1.79 avg | 150,600 | $270K | 100% |
| Filing → |
| DNA | SELL | 2023-12-22 | $133K | — | Filing → |
| DNA | SELL | 2023-12-15 | $173K | — | Filing → |
| DNA | SELL | 2023-12-08 | $99K | — | Filing → |